Corneal Thinning During Topical Bevacizumab Therapy

• Status: Withdrawn
• Trial end date: 2008-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether topical bevacizumab is safe or not when used in corneal neovascularization for long term period.

• Phase: N/A

Details

• Lead Sponsor: Yonsei University
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• clinical diagnosis of corneal neovascularization

• must be able to apply eyedrop

Exclusion Criteria:

• have active keratitis